Concurrently, hepatocyte-derived pro-inflammatory cytokines (e.g., TNF-α, IL-6) and pro-atherogenic lipoproteins are known to propagate endothelial dysfunction, thereby fostering a ‘hepato-cardio–renal axis’ of injury [21]. The gene discussed is TNF; the disease is endothelial dysfunction.